GH Research Plc (GHRS)
22.94
+0.08
(+0.35%)
USD |
NASDAQ |
Oct 02, 16:00
22.93
-0.01
(-0.04%)
After-Hours: 20:00
GH Research Max Drawdown (5Y) : 81.15% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 81.15% |
| August 31, 2026 | 81.15% |
| July 31, 2026 | 81.15% |
| June 30, 2026 | 81.15% |
| May 31, 2026 | 81.15% |
| April 30, 2026 | 81.15% |
| March 31, 2026 | 81.15% |
| February 28, 2026 | 81.15% |
| Date | Value |
|---|---|
| January 31, 2026 | 81.15% |
| December 31, 2025 | 81.15% |
| November 30, 2025 | 81.15% |
| October 31, 2025 | 81.15% |
| September 30, 2025 | 81.15% |
| August 31, 2025 | 81.15% |
| July 31, 2025 | 81.15% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly & Co. | 34.47% |
| Avadel Pharmaceuticals Plc | 90.89% |
| Jazz Pharmaceuticals Plc | 47.55% |
| Cosmo NV | 70.44% |
| Johnson & Johnson | 18.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -15.75 |
| Beta (5Y) | 1.321 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 72.18% |
| Historical Sharpe Ratio (5Y) | -0.0351 |
| Historical Sortino (5Y) | -0.0677 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.86% |